Modified responses to disease in old age
Hanssen, P.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 98(32): 1640-1642
1978
ISSN/ISBN: 0029-2001 PMID: 725879 Document Number: 126426
Document emailed within 1 workday
Related Documents
Schirrmacher, V.; Wigzell, H. 1974: Immune responses against native and chemically modified albumins in mice. II. Effect of electric charge and conformation on the humoral antibody response and on helper T cell responses Journal of Immunology 113(5): 1635-1643Buening, G.M. 1978: Immune responses of cows to a chemically modified anaplasma antigen American Journal of Veterinary Research 39(6): 925-930
Alexandre, C.; Chapuy, M.C.; Meunier, P. 1979: The hypocalcemia test, using human and salmon synthetic calcitonins. Paradoxical hypercalcemic responses. Responses in patients with Paget's disease treated with EHDP Revue du Rhumatisme et des Maladies Osteo-Articulaires 46(5): 335-342
Arora, P.K.; Shearer, G.M. 1981: Non-MHC-linked genetic control of murine cytotoxic T lymphocyte responses to hapten-modified syngeneic cells Journal of Immunology 127(5): 1822-1828
Gieni, R.S.; Yang, X.; HayGlass, K.T. 1993: Allergen-specific modulation of cytokine synthesis patterns and IgE responses in vivo with chemically modified allergen Journal of Immunology 150(1): 302-310
Ojima, T.; Iwahashi, M.; Nakamura, M.; Matsuda, K.; Nakamori, M.; Ueda, K.; Naka, T.; Katsuda, M.; Miyazawa, M.; Iida, T.; Yamaue, H. 2008: Streptococcal preparation OK-432 promotes the capacity of dendritic cells (DCs) to prime carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocyte responses induced with genetically modified DCs that express CEA International Journal of Oncology 32(2): 459-466
Schiff, S.E.; Buckley, R.H. 1987: Modified responses to recipient and donor B cells by genetically donor T cells from human haploidentical bone marrow chimeras Journal of Immunology 138(7): 2088-2094
Tanasanvimon, S.; Ayuthaya, N.I.N.; Phanthumchinda, K. 2007: Modified Parkinson's Disease Sleep Scale (MPDSS) in Thai Parkinson's disease patients Journal of the Medical Association of Thailand 90(11): 2277-2283
Levy, R.B.; Shearer, G.M.; Richardson, J.C.; Henkart, P.A. 1981: Cell-mediated lympholytic responses against autologous cells modified with haptenic sulfhydryl reagents. I. Effector cells can recognize two distinct classes of hapten-reactive self sites on cell surface proteins Journal of Immunology 127(2): 523-528
Parrish, R.A. 1977: Modified Duhamel operation for Hirschsprung's disease American Surgeon 43(5): 283-286
Jovanović, D.; Cvetanović, S.; Grujić, B.; Savić, D. 2001: A modified surgical tehnique in Hirschprung's disease Srpski Arhiv Za Celokupno Lekarstvo 129(Suppl 1): 28-31
Harding, J.J. 1993: Alzheimer disease (AD), modified proteins, and aspirin Alzheimer Disease and Associated Disorders 7(1): 55-58
Karim, A.S.; Weltman, J.K. 1999: Transcription of 2'-deoxy-2'-fluoro-modified and phosphorothioate-modified RNA templates by HIV-1 reverse transcriptase Anticancer Research 19(6b): 5419-5421
Sun, T.; Peng, S.; Narurkar, L. 1994: Modified immunoselection technique for definitive diagnosis of heavy-chain disease Clinical Chemistry 40(4): 664
Augé de Mello, P.; Honigman, M.N.; Fernandes, M.V.; Gomes, I. 1970: Further information on the survival of modified foot-and-mouth disease virus in cattle Bulletin - Office International des Epizooties 73(5): 489-505
Naghdi, S.; Ansari, N.N.; Mansouri, K.; Asgari, A.; Olyaei, G.R.; Kazemnejad, A. 2008: Neurophysiological examination of the Modified Modified Ashworth Scale (MMAS) in patients with wrist flexor spasticity after stroke Electromyography and Clinical Neurophysiology 48(1): 35-41
Pover, G.M.; Dash, C.H. 1985: A new, modified form of inhaler ('Rotahaler') for patients with chronic obstructive lung disease Pharmatherapeutica 4(2): 98-101
Fousteris, M.A.; Koutsourea, A.I.; Arsenou, E.S.; Papageorgiou, A.; Mourelato, D.; Nikolaropoulos, S.S. 2002: Antileukemic and cytogenetic effects of modified and non-modified esteric steroidal derivatives of 4-methyl-3-bis(2-chloroethyl)amino benzoic acid (4-Me-CABA) Anticancer Research 22(4): 2293-2299
Yabanoglu, H.; Karagulle, E.; Belli, S.; Turk, E. 2014: Results of modified Dufourmentel rhomboid flap in patients with extensive Sacrococcygeal pilonidal disease Acta Chirurgica Belgica 114(1): 52-57
Aho, K.; Pyhälä, R. 1974: Agglutinins against human erythrocytes modified by Newcastle disease virus in Mycoplasma pneumoniae infections Clinical and Experimental Immunology 17(4): 607-616